154 related articles for article (PubMed ID: 38244093)
21. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
23. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
[TBL] [Abstract][Full Text] [Related]
24. A meta-analysis of comparisons of various surgical treatments for moyamoya diseases.
Lin K; Sui S; Zhao J; Zhang L; Chen K
Brain Behav; 2021 Oct; 11(10):e2356. PubMed ID: 34520635
[TBL] [Abstract][Full Text] [Related]
25. Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Patients with Moyamoya Disease: Systematic Review and Meta-Analysis.
Yu J; Zhang J; Li J; Zhang J; Chen J
World Neurosurg; 2020 Mar; 135():357-366.e4. PubMed ID: 31759149
[TBL] [Abstract][Full Text] [Related]
26. Perioperative Complications and Long-Term Outcomes After Bypasses in Adults with Moyamoya Disease: A Systematic Review and Meta-Analysis.
Sun H; Wilson C; Ozpinar A; Safavi-Abbasi S; Zhao Y; Nakaji P; Wanebo JE; Spetzler RF
World Neurosurg; 2016 Aug; 92():179-188. PubMed ID: 27150649
[TBL] [Abstract][Full Text] [Related]
27. Hemorrhagic Moyamoya Disease Treatment: A Network Meta-Analysis.
Ding J; Zhou D; Paul Cosky EE; Pan L; Ya J; Wang Z; Jin K; Guan J; Ding Y; Ji X; Meng R
World Neurosurg; 2018 Sep; 117():e557-e562. PubMed ID: 29933090
[TBL] [Abstract][Full Text] [Related]
28. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
29. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
30. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study.
Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Ye X; Liu X; Zhang Q; Wang J; Yang Z; Zhao M; Zhao J
J Neurosurg; 2018 May; 128(5):1327-1337. PubMed ID: 28686113
[TBL] [Abstract][Full Text] [Related]
31. Safety and Efficacy of Induced Hypertension and Hypervolemia in Preventing Neurologic Complications After Combined Direct and Indirect Bypass in Hemorrhagic-Onset Moyamoya Disease.
Li Y; Wang AR; Steinberg GK
World Neurosurg; 2022 Apr; 160():e381-e387. PubMed ID: 35026459
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience.
Thines L; Petyt G; Aguettaz P; Bodenant M; Himpens FX; Lenci H; Henon H; Gauthier C; Hossein-Foucher C; Cordonnier C; Lejeune JP
Rev Neurol (Paris); 2015 Jan; 171(1):31-44. PubMed ID: 25555850
[TBL] [Abstract][Full Text] [Related]
33. Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery.
Czabanka M; Boschi A; Acker G; Peña-Tapia P; Schubert GA; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2016 Oct; 158(10):1895-900. PubMed ID: 27573349
[TBL] [Abstract][Full Text] [Related]
34. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy.
Nielsen TH; Abhinav K; Sussman ES; Han SS; Weng Y; Bell-Stephens T; ; Heit JJ; Steinberg GK
J Neurosurg; 2020 Jun; 134(5):1578-1589. PubMed ID: 32534489
[TBL] [Abstract][Full Text] [Related]
35. Meta-Analysis of Prognosis of Different Treatments for Symptomatic Moyamoya Disease.
Li Q; Gao Y; Xin W; Zhou Z; Rong H; Qin Y; Li K; Zhou Y; Wang J; Xiong J; Dong X; Yang M; Liu Y; Shen J; Wang G; Song A; Zhang J
World Neurosurg; 2019 Jul; 127():354-361. PubMed ID: 30995556
[TBL] [Abstract][Full Text] [Related]
36. Follow-up outcomes of different bypass surgical modalities for adults with ischaemic-type moyamoya disease.
Gao P; Chen D; Yuan S; Kong T; Zhang D; Zhu X; Li X; Zhen Y; Yan D
Br J Neurosurg; 2023 Apr; 37(2):148-157. PubMed ID: 34553657
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Combined Revascularization Surgery for Moyamoya Disease without Preoperative Cerebral Angiography.
Okuyama T; Kawabori M; Ito M; Sugiyama T; Kazumata K; Fujimura M
World Neurosurg; 2022 Sep; 165():e446-e451. PubMed ID: 35750140
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.
Morshed RA; Abla AA; Murph D; Dao JM; Winkler EA; Burkhardt JK; Colao K; Hetts SW; Fullerton HJ; Lawton MT; Gupta N; Fox CK
J Clin Neurosci; 2020 Sep; 79():137-143. PubMed ID: 33070883
[TBL] [Abstract][Full Text] [Related]
39. Direct vs Indirect Revascularization in a North American Cohort of Moyamoya Disease.
Lai PMR; Patel NJ; Frerichs KU; Patel AB; Aziz-Sultan MA; Ogilvy CS; Du R
Neurosurgery; 2021 Jul; 89(2):315-322. PubMed ID: 33957674
[TBL] [Abstract][Full Text] [Related]
40. Revascularization of Moyamoya Angiopathy in Older Adults.
Williamson RW; Abla AA; Zabramski JM; Nakaji P; Spetzler RF; Wanebo JE
World Neurosurg; 2017 Mar; 99():37-40. PubMed ID: 27890765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
